Cyclacel Pharmaceuticals Inc (CYCC)

Cyclacel Pharmaceuticals Inc Azioni (CYCC) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	6.45% 0.029	0.031	0.016	0.373	-
Operating Expenses	18.68% 4.384	5.391	6.861	6.302	7.319
Benefits Costs and Expenses	24.37% 4.329	5.724	6.716	6.407	7.124
Costs And Expenses	24.37% 4.329	5.724	6.716	6.407	7.124
Operating Income/Loss	18.75% -4.355	-5.36	-6.845	-5.929	-7.319
Nonoperating Income/Loss	116.52% 0.055	-0.333	0.145	-0.105	0.195
Income/Loss From Continuing Operations Before Tax	24.47% -4.30	-5.693	-6.70	-6.034	-7.124
Income Tax Expense/Benefit	220.85% -1.354	-0.422	-0.668	-0.586	-1.32
Income/Loss From Continuing Operations After Tax	44.11% -2.946	-5.271	-6.032	-5.448	-5.804
Net Income/Loss	44.58% -2.946	-5.316	-6.032	-5.448	-5.804
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Diluted Earnings Per Share	-2.27	-	-	-0.44	-0.47
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-